hackettg

Pharmacy teams are reminded that they have until the 5 February 2024 to complete and submit the required information for all outstanding referred back (unpaid) prescriptions received prior to July 2022. After 5 February, all referred back prescriptions older than 18 months (including any paper referred back forms sent to pharmacies prior to July 2022) [...]

The post Final reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024 appeared first on Community Pharmacy England.

With New Year’s Day (1 January 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 January 2024, to submit their December FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division [...]

The post Extended FP34C submission deadline for prescriptions dispensed in December 2023 appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 January 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – January 2024 appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/44 Date issued: 14 December 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) PL 50674/0011 SNOMED Code: N/A Batch Number Expiry Date Pack Size First Distributed BF22004504 Dec-2024 12 x 8 27th April [...]

The post MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) appeared first on Community Pharmacy England.

National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products National Patient Safety Alert Reference Number: NatPSA/2023/016/DHSC Date issued: 8th December 2023 Brief description of the problem A Medicine Supply Notification issued on 24 May 2023, detailed a shortage of Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml [...]

The post National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products appeared first on Community Pharmacy England.